Answers are grounded in this paper and cite their sources.
Not only are PAX-FKHR fusion transcripts specific for ARMS, but expression of PAX3-FKHR and PAX7-FKHR identifies a very high-risk subgroup and a favorable outcome subgroup, respectively, among patients presenting with metastatic ARMS.
No takes yet. Share an insight, caveat, or question.
Sorensen et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: